[Note: this publication is no longer available on the SAMHSA website. It is here for archival purposes].

This guide is intended to provide nurses with general information about buprenorphine products—Suboxone® (buprenorphine and naloxone) and Subutex® (buprenorphine)—for the pharmacological treatment of opioid addiction. The guide can also serve as a resource to help nurses working with community physicians to improve treatment outcomes for individuals receiving office-based treatment for opioid addiction.